On February 13, image-guided radiotherapy developer ViewRay filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO) of $69 million.
The company plans to list on the Nasdaq Global Market under the symbol VRAY. No pricing terms were disclosed.